Stay updated with breaking news from Vascular Access. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The US Food and Drug Administration has approved daprodustat as oral treatment for anemia in patients with chronic kidney disease and on dialysis, but not for patients who are not on dialysis.
Although there has been a move towards making extravasations a reportable medical event, a patient advocacy group says the proposed change places the burden on patients rather than healthcare professionals.
Among adults with type 2 diabetes and an eGFR
/PRNewswire/ -- The global vascular access devices market size is expected to reach USD 2.64 billion by 2030, according to a new report by Grand View Research,...
/PRNewswire/ -- Vasc-Alert, a pioneer in vascular access surveillance, today announced the publication of a study in the Journal of Vascular Access validating...